webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG4-propionic acid

  CAS No.: 557756-85-1   Cat No.: BADC-01135   Purity: ≥95% 4.5  

Fmoc-N-amido-PEG4-propionic acid is a bifunctional PEG linker for ADC construction, offering improved aqueous solubility and flexible conjugation strategies in targeted drug delivery.

Fmoc-N-amido-PEG4-propionic acid

Structure of 557756-85-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C26H33NO8
Molecular Weight
487.54
Shipping
Room temperature
Storage
Store at -20°C, keep in dry and avoid sunlight

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
5 g $376 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16-pentaoxa-4-azanonadecan-19-oic acid; Fmoc-N-amido-PEG4-acid; Fmoc-NH-PEG4-CH2CH2COOH; Fmoc-15-Amino-4,7,10,13-tetraoxapentadecacanoic acid; 2,7,10,13,16-Pentaoxa-4-azanonadecan-19-oic acid, 1-(9H-fluoren-9-yl)-3-oxo-; 15-(9-Fluorenylmethyloxycarbonyl)amino-4,7,10,13-tetraoxa-pentadecanoic acid; 5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester; 15-(Fmoc-amino)-4,7,10,13-tetraoxapentadecanoic Acid
IUPAC Name
3-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCC(=O)O
InChI
InChI=1S/C26H33NO8/c28-25(29)9-11-31-13-15-33-17-18-34-16-14-32-12-10-27-26(30)35-19-24-22-7-3-1-5-20(22)21-6-2-4-8-23(21)24/h1-8,24H,9-19H2,(H,27,30)(H,28,29)
InChIKey
NUHRPLKTAAVHCZ-UHFFFAOYSA-N
Density
1.219 g/cm3
Solubility
Soluble in DCM, DMF, DMSO
PSA
112.55000
Appearance
Pale Yellow or Colorless Oily Matter
Quantity
Data not available, please inquire.
Shelf Life
≥ 2 years
Shipping
Room temperature
Storage
Store at -20°C, keep in dry and avoid sunlight
Boiling Point
682.1±55.0 °C at 760 mmHg
Form
Solid
Biological Activity
Fmoc-NH-PEG4-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker

Fmoc-N-amido-PEG4-propionic acid is a high-performance ADC linker extensively applied in antibody-drug conjugate development. Its structure incorporates a PEG4 spacer, which provides controlled flexibility and hydrophilicity, facilitating improved conjugation efficiency between monoclonal antibodies and ADC cytotoxins. The Fmoc-protected amido group enables selective coupling in solid-phase synthesis and bioconjugation procedures, ensuring precise attachment of payloads while maintaining chemical stability under physiological conditions.

In ADC linker design, the PEG4 segment of Fmoc-N-amido-PEG4-propionic acid reduces steric hindrance between the antibody and ADC payload, enhancing accessibility of the cytotoxin and maintaining the antigen-binding capacity of the antibody. This linker is compatible with a variety of cytotoxic payloads, including microtubule inhibitors and DNA-damaging agents, making it suitable for constructing ADCs with defined drug-to-antibody ratios (DAR) and reproducible pharmacokinetic properties.

The chemical characteristics of Fmoc-N-amido-PEG4-propionic acid support site-specific conjugation strategies, enabling controlled ADC payload placement and consistent linker stability. Its hydrophilic PEG4 segment improves solubility and reduces aggregation, which is critical for ADC formulation, storage, and delivery. The linker’s stability ensures that the ADC remains intact in circulation, allowing the cytotoxic payload to reach the target tumor microenvironment effectively.

This ADC linker is widely used in oncology-focused bioconjugation applications, where the combination of PEG4 flexibility, Fmoc-protected functionality, and chemical robustness facilitates the design of ADCs with reliable therapeutic performance. Fmoc-N-amido-PEG4-propionic acid provides a standardized, reproducible tool for precise antibody-to-payload conjugation in advanced ADC research and development.

What is Fmoc-N-amido-PEG4-propionic acid?

Fmoc-N-amido-PEG4-propionic acid is a PEGylated linker used in ADC and peptide conjugation. The Fmoc-protected amide facilitates controlled attachment to biomolecules, while the PEG4 spacer improves solubility and reduces steric hindrance, supporting versatile research applications.

19/10/2017

Dear BOC Sciences, could you advise how Fmoc-N-amido-PEG4-propionic acid should be stored?

It should be stored in a dry, cool, and dark environment, ideally under inert gas. This prevents moisture-induced hydrolysis of the PEG linker and maintains integrity for reliable experimental use in conjugation and ADC research.

13/12/2019

Dear BOC Sciences, could you please provide the specifications of Fmoc-N-amido-PEG4-propionic acid?

Specifications include molecular weight, PEG spacer length, and Fmoc protection, which guide conjugation strategy. These parameters are provided to support precise experimental design without disclosing purity information.

10/9/2018

Could you please confirm if support documents are available for Fmoc-N-amido-PEG4-propionic acid?

Yes, it is supplied with structural data, handling protocols, and storage guidelines. Researchers can use these documents to ensure proper conjugation and reproducibility in ADC or peptide research workflows.

4/8/2016

Dear team, how is the quality of Fmoc-N-amido-PEG4-propionic acid verified?

Quality is confirmed using NMR, LC-MS, and HPLC analyses to validate chemical structure and stability. These tests ensure the linker meets research requirements for conjugation experiments and ADC development.

17/5/2022

— Dr. Olivia Brown, Senior Researcher (UK)

Fmoc-N-amido-PEG4-propionic acid arrived with excellent purity, which was crucial for our peptide-ADC conjugation studies.

10/9/2018

— Mr. David Wilson, Chemistry Scientist (USA)

The product met all our analytical specifications, and the Fmoc-N-amido-PEG4-propionic acid performed reliably in our coupling reactions.

17/5/2022

— Dr. Sofia Rossi, Biochemist (Italy)

We appreciated the prompt delivery of Fmoc-N-amido-PEG4-propionic acid. Its stability under our reaction conditions was outstanding.

4/8/2016

— Ms. Hannah Schmidt, ADC Scientist (Germany)

This linker enabled smooth PEGylation in our ADC constructs. Batch quality and reproducibility were top-notch.

19/10/2017

— Dr. Mark Taylor, Bioconjugation Specialist (Canada)

Fmoc-N-amido-PEG4-propionic acid simplified our conjugation protocol, and the product documentation was thorough and helpful.

— Dr. Isabella Lee, Senior Scientist (USA)

Excellent technical support helped us optimize the use of Fmoc-N-amido-PEG4-propionic acid, ensuring reproducible peptide-ADC yields.

13/12/2019

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-PEG6-NHS ester | NHS-SS-Ph | sulfo-SPDB-DM4 | Eribulin Mesylate | Triptolide | MMAE-SMCC | TCO-PEG12-NHS ester | Sudemycin C | 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | m-PEG6-SS-PEG6-methyl | Fmoc-N-amido-PEG4-propionic acid
Send Inquiry
Verification code
Inquiry Basket